Core Insights - Gerardo Familiar, President of Chemours' Advanced Performance Materials (APM) business, has been appointed to the SEMI North America Advisory Board (NAAB) to support semiconductor innovation and supply chain resilience in North America [1][2][3] Group 1: Appointment and Role - Familiar's appointment to the SEMI NAAB took effect on January 14, 2026, marking the start of his three-year term [3] - The SEMI NAAB serves as the principal advocate for member companies in North America, providing strategic guidance on programs that enhance semiconductor industry growth, supply chain robustness, sustainability, workforce development, and manufacturing excellence [1][2] Group 2: Company Background and Expertise - Chemours is a global leader in industrial and specialty chemicals, serving markets such as coatings, plastics, refrigeration, semiconductor, and advanced electronics [4] - The company operates through three business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, delivering chemistry-based innovations to solve customer challenges [4] - Chemours has approximately 5,700 employees and 28 manufacturing sites, serving around 2,400 customers in approximately 110 countries [4]

Core Insights - The Chemours Company reported a net loss of $47 million or 31 cents per share for Q4 2025, a significant decline from the previous year's net loss of $11 million or 8 cents [1] - Adjusted EBITDA decreased by 24% year over year to $128 million, primarily due to weaker performance in Titanium Technologies and Advanced Performance Materials segments [3] Financial Performance - Q4 net sales were $1,329 million, reflecting a 2.2% decline from the previous year, in line with Zacks Consensus Estimate [2] - Cash provided by operating activities was $137 million, slightly down from $138 million in the prior quarter, while capital expenditures were reduced to $45 million from $109 million year over year [8] Segment Performance - Titanium Technologies division revenues were $561 million, an 11% decrease year over year, but exceeded estimates [4] - Thermal & Specialized Solutions segment saw a 14% year-over-year revenue increase to $444 million, driven by higher prices and volume [5] - Advanced Performance Materials unit revenues amounted to $312 million, a 4% decline year over year, primarily due to an 8% decrease in volume [7] Outlook - The company expects Q1 sales to increase by 3-5% sequentially, with full-year sales growth projected at 3-5% year over year [9] - Adjusted EBITDA is anticipated to be between $120-$150 million for Q1 and $800-$900 million for 2026 [9] - The Titanium Technologies segment is expected to see a sequential decline in net sales, while Thermal & Specialized Solutions is projected to experience a mid-20 to 30% sequential increase [11][12] Stock Performance - Chemours shares have gained 5.5% over the past year, contrasting with a 13.4% decline in the industry [13]

Core Insights - Chemours' shares fell 16.8% following the release of disappointing earnings and guidance that only met analyst expectations [1] - The company reported a 2.2% revenue decline in Q4, with adjusted earnings per share dropping 46% to $0.05, missing expectations by $0.02 [2] - For the upcoming year, Chemours forecasts revenue growth of 3% to 5%, projecting revenues between $5.98 billion and $6.10 billion for 2026 [3] Financial Performance - The adjusted EBITDA is expected to be between $800 million and $900 million, indicating a 14.6% increase at the midpoint compared to 2025's EBITDA of $742 million [3] - The 2025 EBITDA was impacted by a one-time inventory charge in the Advanced Performance Materials segment, which is facing short-term cyclical headwinds [4] Growth Opportunities - Chemours' Opteon low-carbon refrigerants segment showed significant growth, with a 56% increase last year, contributing to a 13% growth in the Thermal Solutions segment [8] - Opteon sales accounted for 22% of Chemours' total sales last year, suggesting potential for further growth if other segments recover [8]

Core Insights - Chemours achieved record annual sales in its Thermal & Specialized Solutions (TSS) segment for 2025, driven by the strong adoption of Opteon refrigerants, which accounted for 75% of total refrigerant sales, up from 56% the previous year [1] - The company reported a significant increase in Opteon sales, with a 37% rise in the fourth quarter compared to the same period last year, attributed to higher pricing and moderate volume increases [2] - Chemours' adjusted EBITDA margins for TSS improved to 32% in 2025, up from 31%, despite an additional $22 million investment in R&D for liquid cooling and next-generation refrigerants [1] Financial Performance - Fourth-quarter net sales met expectations, largely due to TSS's record sales and consistent performance across all divisions, resulting in a free cash flow of $92 million [4] - For the first quarter of 2026, TSS net sales are projected to rise sequentially by 20% to 30%, with Opteon refrigerants expected to increase by 30% to 40% [5] - Chemours anticipates consolidated first-quarter 2026 net sales to increase by 3% to 5% sequentially, with adjusted EBITDA projected between $120 million and $150 million [14] Segment Performance - Advanced Performance Materials (APM) faced near-term end-market weakness, with a projected sequential net sales decline in the high teens percentage range due to a disruption at the Washington Works facility [3][13] - Titanium Technologies (TT) is expected to see a sequential net sales decline in the low- to mid-single digits, with adjusted EBITDA anticipated to be between breakeven and $5 million [8][9] Strategic Initiatives - Chemours is focused on ongoing pricing actions to maintain stability and strength in 2026, with a December pricing announcement contributing to this stability [7] - The company plans to use estimated net proceeds of $300 million from the sale of the Kuan Yin site to reduce outstanding debt and improve its leverage ratio [15] - Chemours has rolled out the "Chemours Business System" to implement lean principles and has made progress in commercializing a two-phase liquid cooling solution, with initial production targeted for the third quarter of 2026 [16] Outlook - For full-year 2026, Chemours projects net sales growth of 3% to 5%, adjusted EBITDA between $800 million and $900 million, and capital expenditures of $275 million to $325 million [17] - The company is continuing a European asset review and has announced the closure of its Villers-Saint-Paul site in France as part of its portfolio updates [18]

Financial Data and Key Metrics Changes - The company reported strong quarterly free cash flow of $92 million, reflecting its long-term cash generation potential [9] - Adjusted EBITDA margins for the TSS business increased to 32%, up from 31% in the prior year, despite additional costs of approximately $22 million in R&D investments [10] - For the full year 2026, the company anticipates overall net sales growth to be between 3% and 5%, with Adjusted EBITDA expected to range from $800 million to $900 million [26] Business Line Data and Key Metrics Changes - The TSS business achieved record sales for Opteon refrigerants, with a 37% increase compared to the prior year quarter, driven by higher pricing and moderate volume increases [9][10] - The TT business is expected to see sequential net sales decrease in the low- to mid-single digits percentage range in the first quarter, with mineral sales anticipated to drop 60% sequentially [18][19] - The APM business is projected to experience a high teens percentage decrease in net sales sequentially due to sustained market weakness and the impact of a facility outage [21] Market Data and Key Metrics Changes - The company noted a strengthening order book in the semiconductor sector, indicating preliminary signs of recovery in the APM business [13] - The TT segment is experiencing stable demand with no major demand triggers expected, while pricing power remains strong [38][72] - The company anticipates that average global pricing for TiO2 pigment will be generally in line with the prior year quarter [19] Company Strategy and Development Direction - The company is focused on executing its Pathway to Thrive strategy, which emphasizes operational excellence, cost management, and cash flow generation [29][35] - The recent sale of the Kuan Yin facility is expected to generate approximately $300 million in net proceeds, which will be used to reduce debt and improve the net leverage ratio [6][27] - The company is committed to enhancing its market position through innovation and strategic portfolio management, including the closure of underperforming sites [32][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to generate cash flow and improve earnings throughout 2026, despite facing challenges in certain end markets [24][35] - The company expects to see continued growth in the TSS business driven by regulatory adoption and market demand for Opteon refrigerants [16][17] - Management highlighted the importance of maintaining operational stability and reliability in light of recent disruptions at key manufacturing facilities [13][14] Other Important Information - The company has made significant progress in reducing corporate-level expenses compared to the same quarter last year, reflecting ongoing efforts in expense management [15] - The company plans to invest approximately $5 million per quarter in liquid cooling and next-generation refrigerant growth opportunities [31] Q&A Session Summary Question: Can you share more detail on the assumptions for TiO2 volume growth in your 2026 guidance? - Management indicated that demand is stable with no major triggers, and they are focused on pricing power [38] Question: Do you have visibility on resolving legacy liabilities during 2026? - Management noted significant progress in addressing legacy liabilities, particularly in New Jersey, and expects updates on other facilities throughout the year [39] Question: Can you provide insights on the APM segment's performance across different end markets? - Management highlighted weaknesses in auto and industrial sectors but noted strong demand in the Performance Solutions portfolio, particularly related to AI and data centers [44] Question: What factors could lead to achieving the high end of your guidance range for the full year? - Management mentioned market evolution, cost improvements, and continued execution on pricing as key factors [78] Question: How do you see the growth algorithm for the TSS business evolving? - Management expects significant growth from the HFO transition and a recovery in the residential segment as new units are put on the market [81]

Financial Data and Key Metrics Changes - The company reported strong quarterly free cash flow of $92 million, reflecting its long-term cash generation potential [9] - Adjusted EBITDA margins for the TSS business increased to 32%, up from 31% in the prior year, despite additional costs of approximately $22 million in R&D investments [10] - For the full year 2026, the company anticipates overall net sales growth to be between 3% and 5%, with Adjusted EBITDA expected to range from $800 million to $900 million [26] Business Line Data and Key Metrics Changes - The TSS business achieved record sales in the fourth quarter, with Opteon sales growing by 37% year-over-year, driven by strong adoption and favorable pricing [9][10] - The TT segment is expected to see sequential net sales decrease in the low- to mid-single digits in the first quarter, with mineral sales anticipated to drop by 60% sequentially [18][19] - The APM business is projected to experience a high teens percentage decrease in net sales sequentially due to market weakness and operational disruptions [21] Market Data and Key Metrics Changes - The company noted a strengthening order book in the semiconductor sector, indicating preliminary signs of recovery in the APM business [13] - The TT segment is facing volume seasonality in certain key markets, but pricing stability has been maintained, laying groundwork for continued pricing strength in 2026 [11] - The company expects average global pricing for TiO2 pigment to be generally in line with the prior year quarter [19] Company Strategy and Development Direction - The company is focused on executing its Pathway to Thrive strategy, which emphasizes operational excellence, cost management, and cash flow generation [29][35] - Recent strategic initiatives include the sale of the Kuanyin site for an estimated net proceeds of $300 million, aimed at reducing outstanding debt [5][27] - The company is committed to improving cash flow generation and aims to achieve a net leverage ratio below 4x adjusted EBITDA by the end of 2026 [27][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of demand across its business segments, with expectations for continued growth driven by regulatory adoption and market recovery [16][17] - The company acknowledged challenges in the APM segment due to operational disruptions but anticipates a return to profitability as operations stabilize [24] - Management highlighted the importance of maintaining pricing power and operational efficiency to navigate market conditions [11][19] Other Important Information - The company has made significant progress in reducing corporate-level expenses compared to the same quarter last year, reflecting ongoing efforts in expense management [15] - The company plans to invest approximately $5 million per quarter in liquid cooling and next-generation refrigerant growth opportunities [31] Q&A Session Summary Question: Can you share more detail on the assumptions for TiO volume growth in your 2026 guidance? - Management indicated that demand is stable with no major triggers expected, focusing on pricing power and stable volumes [38] Question: Do you have visibility on resolving legacy liabilities during 2026? - Management reported significant progress in addressing legacy liabilities, particularly in New Jersey, and expects to provide updates on other facilities throughout the year [39] Question: Can you break down the performance of different end markets in the APM segment? - Management noted weakness in auto and industrial markets but highlighted strong demand in the Performance Solutions portfolio, particularly related to AI and data centers [44] Question: What factors could lead to achieving the high end of your guidance range for the full year? - Management mentioned market evolution, cost improvements, and continued execution on pricing as key factors for reaching the high end of the range [78] Question: How do you see the growth algorithm for the TSS business playing out? - Management expects significant growth from the HFO transition and a recovery in the residential segment as new units are put on the market [81]

Financial Data and Key Metrics Changes - The company reported strong quarterly free cash flow of $92 million, reflecting its long-term cash generation potential [7] - Adjusted EBITDA margins for the TSS business increased to 32%, up from 31% in the prior year, despite additional costs of approximately $22 million in R&D investments [9] - For the full year 2026, the company anticipates overall net sales growth to be between 3% and 5%, with Adjusted EBITDA expected to range from $800 million to $900 million [24] Business Line Data and Key Metrics Changes - The TSS business achieved record sales for Opteon refrigerants, with a 37% increase compared to the prior year quarter, driven by higher pricing and moderate volume increases [8] - The TT business maintained strong execution with adjusted EBITDA remaining ahead due to stabilized pricing and cost performance, despite experiencing volume seasonality in certain key markets [10] - The APM business observed a strengthening order book, particularly within the semiconductor sector, indicating preliminary signs of recovery [12] Market Data and Key Metrics Changes - The company expects net sales for the TSS segment to rise sequentially in the mid-20s to 30% range in the first quarter of 2026, driven by favorable seasonal trends and continued growth in Opteon refrigerants [14] - The TT segment anticipates a sequential net sales decrease in the low- to mid-single digits percentage range in the first quarter, primarily due to weaker seasonal volumes in non-Western markets [16] - The APM segment expects net sales to decrease in the high teens percentage range sequentially due to sustained market weakness and customer timing [19] Company Strategy and Development Direction - The company is focused on executing its Pathway to Thrive strategy, which emphasizes operational excellence, enabling growth, and strengthening long-term commitments [27] - The company plans to use approximately $300 million in net proceeds from the sale of its Kuanyin facility to reduce debt, aiming for a net leverage ratio below 4x adjusted EBITDA by the end of 2026 [25] - The company is committed to driving cash flow generation and improving free cash flow conversion, with a target of above 25% for the year [24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the trajectory of the company, emphasizing the importance of disciplined execution across all pillars of the Pathway to Thrive strategy [33] - The company anticipates that the APM business will finish strong in 2026, with progressively improved sales and earnings as the year progresses [21] - Management noted that while the first quarter did not begin as planned, they are optimistic about recovery and growth opportunities in the semiconductor and data center markets [21] Other Important Information - The company has made significant progress in reducing corporate-level expenses compared to the same quarter last year, reflecting ongoing efforts in expense management [13] - The company is restructuring its mining operations to support overall cost efforts and promote improved cash generation [11] - The company has rolled out the Chemours Business System to embed lean principles and drive increased productivity across the organization [28] Q&A Session All Questions and Answers Question: Could you share some more detail on the assumptions for TiO volume growth that are embedded in your 2026 guidance? - Management indicated that demand is stable with no major demand triggers, focusing on pricing power and stable volumes [36] Question: Do you have line of sight for meaningful progress towards resolving legacy liabilities during 2026? - Management confirmed significant progress in the fourth pillar of strengthening the long term, with ongoing efforts in New Jersey, West Virginia, and North Carolina [38] Question: Can you peel apart some of the different end markets in the APM segment? - Management noted that while auto and industrial production are down, there is strong demand in the Performance Solutions portfolio, particularly related to AI and data centers [42] Question: Can you walk through the three geographies with anti-dumping activities? - Management reported benefits from anti-dumping duties in Brazil and Europe, with ongoing confidence in the situation in India [57] Question: What impact has the Corpus Christi facility had on costs and benefits? - Management stated that the facility is on a two-year ramp, with expected improvements in margins from cost reductions and pricing [58] Question: What would get you to the high end of your range for the full year? - Management indicated that the high end depends on market evolution, cost improvements, and continued execution on pricing [74]

Core Viewpoint - Chemours reported quarterly earnings per share of 5 cents, which is 2 cents lower than Wall Street expectations [1] Financial Performance - The earnings per share of 5 cents indicates a shortfall compared to analyst forecasts, reflecting potential challenges in meeting market expectations [1]

THE CHEMOURS COMPANY Q4 & FULL YEAR 2025 EARNINGS PRESENTATION February 20, 2026 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or ...

Core Viewpoint - Chemours reported a revenue of $1.33 billion for the quarter ended December 2025, reflecting a 2.2% decline year-over-year, with an EPS of $0.05 compared to $0.11 in the same quarter last year, indicating a significant EPS surprise of +2400% against a consensus estimate of $0 [1] Revenue Performance - Revenues from the Other Segment were $12 million, slightly below the average estimate of $12.65 million, marking a year-over-year decline of -7.7% [4] - Titanium Technologies generated revenues of $561 million, exceeding the average estimate of $548.65 million, but still showing an -11.2% year-over-year decrease [4] - Advanced Performance Materials reported revenues of $312 million, surpassing the estimated $302.82 million, yet reflecting a -3.7% change compared to the previous year [4] - Thermal & Specialized Solutions achieved revenues of $444 million, slightly below the estimated $447.37 million, but showing a positive year-over-year change of +13.9% [4] Adjusted EBITDA Analysis - Adjusted EBITDA for Titanium Technologies was $23 million, exceeding the average estimate of $17.47 million [4] - The Other Segment's Adjusted EBITDA was $1 million, compared to the average estimate of $0.87 million [4] - Advanced Performance Materials reported an Adjusted EBITDA of $12 million, significantly lower than the estimated $34.36 million [4] - Thermal & Specialized Solutions had an Adjusted EBITDA of $128 million, which was below the average estimate of $135.12 million [4] Stock Performance - Chemours shares have returned +30.6% over the past month, contrasting with a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]